Real World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease: Interim Results on Decision Impact and Outcomes.

Joji Tokita,Aida Vega,Catherine Sinfield,Nidhi Naik,Shivani Rathi, Sharlene Martin,Stephanie Wang,Leonard Amoruso,Azadeh Zabetian,Steven G Coca,Girish N Nadkarni,Fergus Fleming,Michael J Donovan, Robert Fields

Journal of primary care & community health（2022）

引用 1|浏览4

暂无评分

摘要

The combination of KidneyIntelX, clinical guidelines and educational support resulted in changes in clinical management by clinicians. After testing, there was an increase in visit frequency, referrals for disease management, and introduction to guideline-recommended medications. These differed by risk category, indicating an impact of KidneyIntelX risk stratification on clinical care.

查看译文

关键词

KidneyIntelX,Real World Evidence,decision impact study,diabetic kidney disease,early-stage

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要